
BB Biotech AG
BBAGF
Updated: 03/11/2026, 12:03:54
No historical data available
BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, towards cell, gene and particularly RNA-based technologies. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.
No summaries found.
- Share price
- $62.91
- Market cap
- $4.83B
- Exchange
- OTC
- Currency
- USD
- CEO
- Daniel Koller
- Employees
- 10
- IPO date
- 12/10/2015
- Beta
- 0.622
- Last dividend
- $0.00
- Day range
- $62.91 – $62.91
- 52-week range
- $33.65 – $76.06
- 1-day performance
- -2.26%
- 1-year performance
- 86.97%
- Current drawdown (1Y)
- -17.29%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- CH0038389992
- Created
- 07/12/2025, 02:55:36
- Last update
- 03/11/2026, 12:03:54
Track BB Biotech AG with an AI analyst
See which prediction-market events move BBAGF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.